In the world of biotechnology investing, companies often struggle to bring new drugs to market. Developing treatments for rare diseases can be incredibly expensive, and because these conditions affect ...

- Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of pivotal clinical trial in 2026 - Updated electronics ...

DUBLIN, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...

Earlier this week, the congressionally-mandated National Security Commission on Emerging Biotechnology released its major report, titled “Charting the Future of Biotechnology.” The bipartisan and ...

For biotech firms, a bit of positive news—a key result from clinical trials or new drug discovery, say—can be the difference between a major rally based on a path toward sustained profitability and a ...

New faculty-designed case is academic centerpiece for Biotech & Healthcare contest, which marks its fifth year by attracting scholars from top schools worldwide 12/10/2008 - Business students from ...

India’s bioeconomy has expanded from about USD 10 billion in 2014 to more than USD 195 billion in 2025, reflecting a massive ...

The biotechnology sector continues to reward companies that successfully secure funding to advance late-stage clinical programs, particularly when those financings are completed at premiums to market.